Product Information

LUBIPROSTONE 8 MCG CAPSULE is a generic product labeled by Par Health USA, LLC, priced at $0.5674 per EA under NDC 00254302802. Its NADAC has been published 291 times since Apr 21, 2021.

FDA first approved this application on Jan 31, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LUBIPROSTONE 8 MCG CAPSULE

Lubiprostone
$0.5674per EA

Strength

8 ug/1

NDC

00254302802

Classification

Generic

Dosage Form

CAPSULE, GELATIN COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

LUBIPROSTONE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021908

FDA Approved

1/31/2006

TE Code

AB

On Market Since

1/1/2021

Pharmacological Classes

Chloride Channel Activator
Chloride Channel Activators

Price Statistics

The NADAC for LUBIPROSTONE 8 MCG CAPSULE has been published 291 times since Apr 21, 2021, and over the history we have for it it has declined 88.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5674 per EA
All-time high$4.8390 (Mar 16, 2022)
All-time low$0.5447 (Nov 20, 2024)
52-week high$0.7562
52-week low$0.5493
Median price$0.9284
Average price$2.2189
Largest weekly change-46.8% (Dec 20, 2023)
Weeks tracked291
Tracking sinceApr 21, 2021

Price History

1W

0.0%

1M

+0.4%

3M

+2.0%

6M

-25.0%

1Y

-18.8%

3Y

-69.3%

5Y

-87.8%

All

-88.1%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LUBIPROSTONE 8 MCG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LUBIPROSTONE 8 MCG CAPSULE, manufactured by Par Health USA, LLC, is $0.5674 per EA (NDC 00254302802), effective Nov 11, 2026.

How has the price of LUBIPROSTONE 8 MCG CAPSULE changed over time?

Over the history we have for it, the NADAC for LUBIPROSTONE 8 MCG CAPSULE has declined 88.1%. It has been tracked across 291 weekly CMS publications since Apr 21, 2021.

What are the highest and lowest recorded NADAC prices for LUBIPROSTONE 8 MCG CAPSULE?

Since Apr 21, 2021, the NADAC for LUBIPROSTONE 8 MCG CAPSULE has ranged from a low of $0.5447 (Nov 20, 2024) to a high of $4.8390 (Mar 16, 2022), with a median of $0.9284 per EA.

Are there cheaper alternatives to LUBIPROSTONE 8 MCG CAPSULE?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LUBIPROSTONE 8 MCG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures LUBIPROSTONE 8 MCG CAPSULE?

LUBIPROSTONE 8 MCG CAPSULE (NDC 00254302802) is labeled by Par Health USA, LLC, and CMS classifies it as a generic product.